Axogen, Inc. (AXGN) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Axogen, Inc. (AXGN) closed at USD 35.14 on 2026-10-14, a change of +94.4 % over the past year, with a market capitalization of USD 2.09B.

Axogen, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Axogen, Inc. key figures

Previous close

USD 35.14 (2026-10-14)

1-year change

+94.4 %

Market cap

USD 2.09B

Enterprise value

USD 1.82B

P/E ratio (trailing)

-53.99

P/E ratio (forward)

49.42

EPS (trailing)

-0.66

EPS (forward)

0.72

PEG ratio

99.04

Price to book

7.46

Revenue growth

23.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.70

Employees

622

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Axogen, Inc.

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Axogen, Inc. and compare it with other stocks.